• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸氧化酶破坏乳酸激活的RAS和PI3K致癌信号通路。

Lactate Oxidase Disrupts Lactate-Activated RAS and PI3K Oncogenic Signaling.

作者信息

Keller Chandler R, Martinez Steve R, Keltz Alexys, Chen Michelle, Li Weimin

机构信息

Department of Translational Medicine and Physiology, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA.

Department of Surgery, The Everett Clinic, Part of Optum, Everett, WA 98201, USA.

出版信息

Cancers (Basel). 2024 Aug 10;16(16):2817. doi: 10.3390/cancers16162817.

DOI:10.3390/cancers16162817
PMID:39199589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11353192/
Abstract

LOX was recently shown to inhibit cancer cell proliferation and tumor growth. The mechanism of this inhibition, however, has been exclusively attributed to LOX depletion of TME lactate, a cancer cell energy source, and production of HO, an oxidative stressor. We report that TME lactate triggers the assembly of the lactate receptor hydroxycarboxylic acid receptor 1 (HCAR1)-associated protein complex, which includes GRB2, SOS1, KRAS, GAB1, and PI3K, for the activation of both the RAS and the PI3K oncogenic signaling pathways in breast cancer (BCa) cells. LOX treatment decreased the levels of the proteins in the protein complex via induction of their proteasomal degradation. In addition, LOX inhibited lactate-stimulated expression of the lactate transporters MCT1 and MCT4. Our data suggest that HCAR1 activation by lactate is crucial for the assembly and function of the RAS and PI3K signaling nexus. Shutting down lactate signaling by disrupting this nexus could be detrimental to cancer cells. HCAR1 is therefore a promising target for the control of the RAS and the PI3K signaling required for BCa progression. Thus, our study provides insights into lactate signaling regulation of cancer progression and extends our understanding of LOX's functional mechanisms that are fundamental for exploring its therapeutic potential.

摘要

最近研究表明,赖氨酰氧化酶(LOX)可抑制癌细胞增殖和肿瘤生长。然而,这种抑制机制完全归因于LOX消耗了肿瘤微环境(TME)中的乳酸(一种癌细胞能量来源)以及产生了氧化应激源羟基自由基(HO)。我们报告称,TME乳酸触发了乳酸受体羟基羧酸受体1(HCAR1)相关蛋白复合物的组装,该复合物包括生长因子受体结合蛋白2(GRB2)、七号染色体上的鸟嘌呤核苷酸交换因子1(SOS1)、Kirsten大鼠肉瘤病毒癌基因(KRAS)、GRB2相关结合蛋白1(GAB1)和磷脂酰肌醇-3激酶(PI3K),从而激活乳腺癌(BCa)细胞中的RAS和PI3K致癌信号通路。LOX处理通过诱导蛋白复合物中蛋白质的蛋白酶体降解,降低了这些蛋白质的水平。此外,LOX抑制了乳酸刺激的乳酸转运蛋白单羧酸转运蛋白1(MCT1)和单羧酸转运蛋白4(MCT4)的表达。我们的数据表明,乳酸对HCAR1的激活对于RAS和PI3K信号枢纽的组装和功能至关重要。通过破坏这种信号枢纽来关闭乳酸信号可能对癌细胞有害。因此,HCAR1是控制BCa进展所需的RAS和PI3K信号传导的一个有前景的靶点。因此,我们的研究为癌症进展的乳酸信号调节提供了见解,并扩展了我们对LOX功能机制的理解,这对于探索其治疗潜力至关重要。

相似文献

1
Lactate Oxidase Disrupts Lactate-Activated RAS and PI3K Oncogenic Signaling.乳酸氧化酶破坏乳酸激活的RAS和PI3K致癌信号通路。
Cancers (Basel). 2024 Aug 10;16(16):2817. doi: 10.3390/cancers16162817.
2
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma.乳酸诱导单羧酸转运蛋白1(MCT1)和羟基羧酸受体1(HCAR1)的表达以促进胶质母细胞瘤的肿瘤生长和进展。
Front Oncol. 2022 Apr 28;12:871798. doi: 10.3389/fonc.2022.871798. eCollection 2022.
3
L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.L-乳酸和D-乳酸通过抑制组蛋白脱乙酰酶和激活羟基羧酸受体1来增强DNA修复并调节宫颈癌细胞对抗癌药物的耐药性。
Cell Commun Signal. 2015 Jul 25;13:36. doi: 10.1186/s12964-015-0114-x.
4
The Lactate Receptor HCAR1 Modulates Neuronal Network Activity through the Activation of G and G Subunits.乳酸受体 HCAR1 通过激活 G 和 G 亚基调节神经元网络活动。
J Neurosci. 2019 Jun 5;39(23):4422-4433. doi: 10.1523/JNEUROSCI.2092-18.2019. Epub 2019 Mar 29.
5
Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth.展示有乳酸氧化酶/过氧化氢酶的纳米粒子能有效地消耗肿瘤微环境中的乳酸,从而有效地抑制肿瘤生长。
J Nanobiotechnology. 2023 Jan 3;21(1):5. doi: 10.1186/s12951-022-01762-6.
6
Lactate receptor HCAR1 regulates cell growth, metastasis and maintenance of cancer‑specific energy metabolism in breast cancer cells.乳酸受体 HCAR1 调节乳腺癌细胞的细胞生长、转移和维持特定于癌症的能量代谢。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12784. Epub 2022 Jul 1.
7
HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications.HCAR1/MCT1 通过乳酸介导的 AMPK-SCD1 活性调控肿瘤铁死亡及其治疗意义。
Cell Rep. 2020 Dec 8;33(10):108487. doi: 10.1016/j.celrep.2020.108487.
8
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.癌基因和炎症重塑肿瘤微环境中的宿主能量代谢:RAS 和 NFκB 靶向基质 MCT4。
Cell Cycle. 2013 Aug 15;12(16):2580-97. doi: 10.4161/cc.25510. Epub 2013 Jul 8.
9
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype.乳酸重写葡萄膜黑素瘤细胞的代谢重编程并诱导静止表型。
Int J Mol Sci. 2022 Dec 20;24(1):24. doi: 10.3390/ijms24010024.
10
Stimulation of lactate receptor (HCAR1) affects cellular DNA repair capacity.刺激乳酸受体(HCAR1)会影响细胞的DNA修复能力。
DNA Repair (Amst). 2017 Apr;52:49-58. doi: 10.1016/j.dnarep.2017.02.007. Epub 2017 Feb 20.

引用本文的文献

1
Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?肿瘤微环境中的乳酸:它是癌症进展标志物、免疫抑制剂和治疗靶点吗?
Molecules. 2025 Apr 15;30(8):1763. doi: 10.3390/molecules30081763.
2
Pain, lactate, and anesthetics: intertwined regulators of tumor metabolism and immunity.疼痛、乳酸与麻醉剂:肿瘤代谢与免疫的相互交织的调节因子。
Front Oncol. 2025 Mar 17;15:1534300. doi: 10.3389/fonc.2025.1534300. eCollection 2025.

本文引用的文献

1
Ultrasound-enhanced cascade chemodynamic tumor nanotherapy with lactic acid-enabled hydrogen peroxide self-production.超声增强级联化学动力学肿瘤纳米治疗,具有乳酸促进的过氧化氢自产生。
Biomater Sci. 2023 Feb 14;11(4):1486-1498. doi: 10.1039/d2bm01267g.
2
Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth.展示有乳酸氧化酶/过氧化氢酶的纳米粒子能有效地消耗肿瘤微环境中的乳酸,从而有效地抑制肿瘤生长。
J Nanobiotechnology. 2023 Jan 3;21(1):5. doi: 10.1186/s12951-022-01762-6.
3
Dual Closed-Loop of Catalyzed Lactate Depletion and Immune Response to Potentiate Photothermal Immunotherapy.
催化乳酸消耗与免疫反应的双闭环增强光热免疫疗法
ACS Appl Mater Interfaces. 2022 May 17. doi: 10.1021/acsami.2c07254.
4
A two-component protein condensate of the EGFR cytoplasmic tail and Grb2 regulates Ras activation by SOS at the membrane.EGFR 胞质尾和 Grb2 的双组份蛋白凝聚物在膜上通过 SOS 调节 Ras 的激活。
Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2122531119. doi: 10.1073/pnas.2122531119. Epub 2022 May 4.
5
Human Breast Extracellular Matrix Microstructures and Protein Hydrogel 3D Cultures of Mammary Epithelial Cells.人乳腺细胞外基质微结构及乳腺上皮细胞的蛋白质水凝胶3D培养
Cancers (Basel). 2021 Nov 22;13(22):5857. doi: 10.3390/cancers13225857.
6
Lactate Is a Metabolic Mediator That Shapes Immune Cell Fate and Function.乳酸是一种塑造免疫细胞命运和功能的代谢介质。
Front Physiol. 2021 Oct 18;12:688485. doi: 10.3389/fphys.2021.688485. eCollection 2021.
7
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.乳酸诱导的肿瘤微环境免疫抑制的致癌和临床意义。
Cancer Lett. 2021 Mar 1;500:75-86. doi: 10.1016/j.canlet.2020.12.021. Epub 2020 Dec 23.
8
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment.肿瘤微环境中的乳酸:癌症进展与治疗中的关键分子
Cancers (Basel). 2020 Nov 3;12(11):3244. doi: 10.3390/cancers12113244.
9
Distinct phenotypes of cancer cells on tissue matrix gel.癌细胞在组织基质凝胶上的不同表型。
Breast Cancer Res. 2020 Jul 31;22(1):82. doi: 10.1186/s13058-020-01321-7.
10
Openwork@Dendritic Mesoporous Silica Nanoparticles for Lactate Depletion and Tumor Microenvironment Regulation.介孔树枝状二氧化硅纳米载体用于乳酸耗竭和肿瘤微环境调控。
Angew Chem Int Ed Engl. 2020 Dec 1;59(49):22054-22062. doi: 10.1002/anie.202001469. Epub 2020 Oct 7.